Every program staffed with a dedicated cross-functional team and a Program Management Officer who runs the project. Transparent project management, real-time data exchange, and decisions made in the room with you.
Every program is staffed with a dedicated cross-functional team — synthetic biology, process development, analytical, manufacturing, quality, regulatory, and a Program Management Officer who owns the relationship. You have one point of contact. They have an organization behind them.
Working with us doesn't mean dropping your program off and waiting for results. It means staying close to it, with full visibility into every decision and every data point — and a team that wants you in the room.
Risk assessments, study designs, development plans — they're co-developed with you. Every relevant decision is yours to make; we provide the data and the recommendation.
A Phase 1 IND-enabling program does not need the same governance structure as a commercial transfer. We scale the formality to the stage, never the other way around.
Most CDMOs operate as a black box. We share data, decisions, deviations, and timelines in real time — because surprises are the enemy of a successful CMC program.
Many of our team have been on the innovator side themselves. We treat your program like our own — because we know what it feels like to need it to work.
Quality, manufacturing, and program decisions are championed by senior management — not delegated. When something needs to escalate, you're not chasing layers of project managers. You're in the room with the people who own the direction.
The full set of capabilities that make up our integrated CDMO platform.
SynBio research, ML-driven optimization, proprietary tools for next-gen therapies.
End-to-end autologous & allogeneic workflows — CAR-T, NK, Treg, in-vivo GT.
Adherent & suspension lentivirus — 2 L to 200 L GMP. Targeting and control built in.
Engineering, Master, and Working cell bank generation. Adherent & suspension.
Knowledge transfer as a discipline. Development-to-GMP in ~7 months.